XML 59 R34.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaboration and License Agreements - Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]        
Revenue $ 0 $ 146,267 $ 3,551 $ 208,813
GSK        
Disaggregation of Revenue [Line Items]        
Revenue 0 30,000 2,685 29,323
Horizon        
Disaggregation of Revenue [Line Items]        
Revenue 0 0 0 21,667
Takeda        
Disaggregation of Revenue [Line Items]        
Revenue 0 116,156 866 132,468
Janssen        
Disaggregation of Revenue [Line Items]        
Revenue 0 111 0 355
Amgen        
Disaggregation of Revenue [Line Items]        
Revenue $ 0 $ 0 $ 0 $ 25,000